Grape King Bio Ltd
Grape King Bio Ltd (TAI: 1707) is trading at NT$85.70, about ₹259 at today's TWD/INR rate, as of 30 Sep 2026, 1:30 AM ET, down 0.23% today. Grape King Bio is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
NT$85.70
Today's high
NT$86.40
52 week low
NT$85.70
52 week high
NT$130.50
1707 opened at NT$85.90, closed previously at NT$85.90, and has traded between NT$85.70 and NT$130.50 over the past 52 weeks.
About
Grape King Bio Ltd. is a Taiwanese enterprise specializing in the production and distribution of a diverse array of health-focused items, encompassing pharmaceuticals, traditional remedies, nourishing beverages, and dietary supplements. Its market presence spans Taiwan, mainland China, and various international regions. The company engages with customers through multiple operational avenues, including multi-level marketing channels, conventional distribution networks, and a significant original design and equipment manufacturing (ODM/OEM) division. Among its extensive product range are various mushroom mycelium derivatives, notably ganoderma lucidum, agaricus blazei, antrodia cinnamomea, cordyceps sinensis, and coriolus versicolor. Additionally, it formulates and supplies probiotics featuring strains like enterococcus, bifidobacterium, lactobacillus, pediococcus, streptococcus, saccharomyces, and clostridium, alongside a selection of enzyme products. Beyond its own brand, Grape King Bio offers comprehensive contract services, such as original equipment manufacturing (OEM), original design manufacturing (ODM), custom formulation development, dedicated research and development support, and the provision of raw materials. Established in 1969, the firm maintains its corporate headquarters in Taoyuan City, Taiwan.
Key statistics
Avg. volume
483.25K
Market cap
NT$12.70B
P/E Ratio
11.06
Price-to-sales ratio
1.25
Enterprise value
NT$24.69B
Free cash flow yield
6.06%
Debt-to-equity ratio
0.02
Return on equity
11.78%
ROIC
14.00%
Beta
0.23
Dividend yield
7.00%
Last dividend
NT$6.00
Financial overview
Revenue
NT$10.25B
Earnings per share
NT$8.22
Free cash flow
NT$1.73B
Net profit margin
11.34%
Gross margin
72.88%
EBITDA
NT$2.69B
Revenue growth
-8.14%
Similar securities
This is not an investment recommendation
Grape King Bio for Indian investors
Grape King Bio is listed on the Taiwan Stock Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Grape King Bio for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 1:30 pm SGT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Grape King Bio’s current yield is 7.00%.Dividend tax explained
FAQs
Can I buy Grape King Bio on Paasa?
Grape King Bio (1707) has been listed on the Taiwan Stock Exchange since 1982, in the Drug Manufacturers - Specialty & Generic industry. Grape King Bio is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Grape King Bio share cost in rupees?
One Grape King Bio share is NT$85.70 — about ₹259 at a TWD/INR rate of 3.02 on 29 Sep 2026. Both the Grape King Bio price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Grape King Bio shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the TWD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Grape King Bio price.
Does Grape King Bio pay a dividend, and how is it taxed in India?
Yes. Grape King Bio pays a dividend and the current yield is 7.00%; the last declared dividend was NT$6.00 per share, about ₹18.10. Dividends are taxed at your slab rate in India.
When does TAI trade, in Indian time?
The Taiwan Stock Exchange trades 6:30 am – 11:00 am IST in Indian time.
Do I have to declare Grape King Bio shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Grape King Bio?
Yes. Grape King Bio is priced in TWD, so your rupee outcome combines the TWD move with the TWD/INR move between the day you remit and the day you convert back.